These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31281067)

  • 1. Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease.
    Ivancovsky-Wajcman D; Fliss-Isakov N; Salomone F; Webb M; Shibolet O; Kariv R; Zelber-Sagi S
    Dig Liver Dis; 2019 Dec; 51(12):1698-1705. PubMed ID: 31281067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.
    Da Silva HE; Arendt BM; Noureldin SA; Therapondos G; Guindi M; Allard JP
    J Acad Nutr Diet; 2014 Aug; 114(8):1181-94. PubMed ID: 24631112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.
    Vos MB; Colvin R; Belt P; Molleston JP; Murray KF; Rosenthal P; Schwimmer JB; Tonascia J; Unalp A; Lavine JE;
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):90-6. PubMed ID: 22197855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.
    Wei J; Lei GH; Fu L; Zeng C; Yang T; Peng SF
    PLoS One; 2016; 11(1):e0147985. PubMed ID: 26824361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.
    Chen G; Ni Y; Nagata N; Xu L; Ota T
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women.
    Zelber-Sagi S; Ivancovsky-Wajcman D; Fliss-Isakov N; Hahn M; Webb M; Shibolet O; Kariv R; Tirosh O
    Antioxidants (Basel); 2020 Jul; 9(7):. PubMed ID: 32630732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between dietary antioxidant intake and physical activity rate with nonalcoholic fatty liver disease (NAFLD): A case - Control study.
    Lotfi A; Saneei P; Hekmatdost A; Salehisahlabadi A; Shiranian A; Ghiasvand R
    Clin Nutr ESPEN; 2019 Dec; 34():45-49. PubMed ID: 31677710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
    Kim SK; Kim KI; Kim SR
    Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease.
    Guerrerio AL; Colvin RM; Schwartz AK; Molleston JP; Murray KF; Diehl A; Mohan P; Schwimmer JB; Lavine JE; Torbenson MS; Scheimann AO
    Am J Clin Nutr; 2012 Apr; 95(4):892-900. PubMed ID: 22338037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
    Ji HF; Sun Y; Shen L
    Nutrition; 2014 Sep; 30(9):986-91. PubMed ID: 24976430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between dietary total antioxidant capacity and hepatocellular ballooning in nonalcoholic steatohepatitis: a cross-sectional study.
    de Oliveira DG; de Faria Ghetti F; Moreira APB; Hermsdorff HHM; de Oliveira JM; de Castro Ferreira LEVV
    Eur J Nutr; 2019 Sep; 58(6):2263-2270. PubMed ID: 30019089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between dietary antioxidant index (DAI) and nonalcoholic fatty liver disease (NAFLD) onset; new findings from an incident case-control study.
    Vahid F; Rahmani D; Hekmatdoost A
    Clin Nutr ESPEN; 2021 Feb; 41():360-364. PubMed ID: 33487290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease.
    Salomone F; Ivancovsky-Wajcman D; Fliss-Isakov N; Webb M; Grosso G; Godos J; Galvano F; Shibolet O; Kariv R; Zelber-Sagi S
    JHEP Rep; 2020 Apr; 2(2):100069. PubMed ID: 32195455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.
    Viglino D; Jullian-Desayes I; Minoves M; Aron-Wisnewsky J; Leroy V; Zarski JP; Tamisier R; Joyeux-Faure M; Pépin JL
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28596431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.
    Zelber-Sagi S; Bord S; Dror-Lavi G; Smith ML; Towne SD; Buch A; Webb M; Yeshua H; Nimer A; Shibolet O
    World J Gastroenterol; 2017 Mar; 23(10):1881-1890. PubMed ID: 28348495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Dietary Selenium Intake and the Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.
    Wu J; Zeng C; Yang Z; Li X; Lei G; Xie D; Wang Y; Wei J; Yang T
    J Am Coll Nutr; 2020 Feb; 39(2):103-111. PubMed ID: 31157605
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea.
    Minville C; Hilleret MN; Tamisier R; Aron-Wisnewsky J; Clement K; Trocme C; Borel JC; Lévy P; Zarski JP; Pépin JL
    Chest; 2014 Mar; 145(3):525-533. PubMed ID: 24264333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.